| Tretinoin | Approved Investigational Nutraceutical | XK | 7504 |
downregulated | Tretinoin results in decreased expression of XK mRNA | Xp21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | XKR4 | 114786 |
upregulated | Tretinoin results in increased expression of XKR4 mRNA | 8q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | XPO1 | 7514 |
downregulated | Tretinoin results in decreased expression of XPO1 mRNA | 2p15 | |
| Tretinoin | Approved Investigational Nutraceutical | XPO5 | 57510 |
downregulated | Tretinoin results in decreased expression of XPO5 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | XPO6 | 23214 |
downregulated | Tretinoin results in decreased expression of XPO6 mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | XPO7 | 23039 |
downregulated | Tretinoin results in decreased expression of XPO7 mRNA | 8p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | XPOT | 11260 |
downregulated | Tretinoin results in decreased expression of XPOT mRNA | 12q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | XPR1 | 9213 |
upregulated | Tretinoin results in increased expression of XPR1 mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | XYLT1 | 64131 |
upregulated | Tretinoin results in increased expression of XYLT1 mRNA | 16p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | YBX1 | 4904 |
downregulated | Tretinoin results in decreased expression of YBX1 mRNA | 1p34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | YEATS4 | 8089 |
downregulated | Tretinoin results in decreased expression of YEATS4 mRNA | 12q15 | |
| Tretinoin | Approved Investigational Nutraceutical | YIF1B | 90522 |
downregulated | Tretinoin results in decreased expression of YIF1B mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | YKT6 | 10652 |
downregulated | Tretinoin results in decreased expression of YKT6 mRNA | 7p13 | |
| Tretinoin | Approved Investigational Nutraceutical | YPEL2 | 388403 |
upregulated | Tretinoin results in increased expression of YPEL2 mRNA | 17q22 | |
| Tretinoin | Approved Investigational Nutraceutical | YPEL4 | 219539 |
upregulated | Tretinoin results in increased expression of YPEL4 mRNA | 11q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | YPEL5 | 51646 |
upregulated | Tretinoin results in increased expression of YPEL5 mRNA | 2p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | YTHDC1 | 91746 |
downregulated | Tretinoin results in decreased expression of YTHDC1 mRNA | 4q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | YWHAH | 7533 |
downregulated | Tretinoin results in decreased expression of YWHAH mRNA | 22q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | YWHAZ | 7534 |
downregulated | Tretinoin results in decreased expression of YWHAZ mRNA | 8q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ZADH2 | 284273 |
upregulated | Tretinoin results in increased expression of ZADH2 mRNA | 18q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ZBED5 | 58486 |
upregulated | Tretinoin results in increased expression of ZBED5 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | ZBED6CL | 113763 |
downregulated | Tretinoin results in decreased expression of ZBED6CL mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ZBED8 | 63920 |
downregulated | Tretinoin results in decreased expression of ZBED8 mRNA | 5q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ZBTB16 | 7704 |
downregulated | Tretinoin results in decreased expression of ZBTB16 mRNA | 11q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ZBTB20 | 26137 |
upregulated | Tretinoin results in increased expression of ZBTB20 mRNA | 3q13.31 | |